These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34162751)
1. Functional human IgA targets a conserved site on malaria sporozoites. Tan J; Cho H; Pholcharee T; Pereira LS; Doumbo S; Doumtabe D; Flynn BJ; Schön A; Kanatani S; Aylor SO; Oyen D; Vistein R; Wang L; Dillon M; Skinner J; Peterson M; Li S; Idris AH; Molina-Cruz A; Zhao M; Olano LR; Lee PJ; Roth A; Sinnis P; Barillas-Mury C; Kayentao K; Ongoiba A; Francica JR; Traore B; Wilson IA; Seder RA; Crompton PD Sci Transl Med; 2021 Jun; 13(599):. PubMed ID: 34162751 [TBL] [Abstract][Full Text] [Related]
2. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals. Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS Malar J; 2009 Oct; 8():235. PubMed ID: 19852802 [TBL] [Abstract][Full Text] [Related]
3. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525 [TBL] [Abstract][Full Text] [Related]
6. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge. Chatterjee S; Wery M; Sharma P; Chauhan VS Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073 [TBL] [Abstract][Full Text] [Related]
7. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver. Wang LT; Pereira LS; Flores-Garcia Y; O'Connor J; Flynn BJ; Schön A; Hurlburt NK; Dillon M; Yang ASP; Fabra-García A; Idris AH; Mayer BT; Gerber MW; Gottardo R; Mason RD; Cavett N; Ballard RB; Kisalu NK; Molina-Cruz A; Nelson J; Vistein R; Barillas-Mury C; Amino R; Baker D; King NP; Sauerwein RW; Pancera M; Cockburn IA; Zavala F; Francica JR; Seder RA Immunity; 2020 Oct; 53(4):733-744.e8. PubMed ID: 32946741 [TBL] [Abstract][Full Text] [Related]
8. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children. Kurtovic L; Behet MC; Feng G; Reiling L; Chelimo K; Dent AE; Mueller I; Kazura JW; Sauerwein RW; Fowkes FJI; Beeson JG BMC Med; 2018 Apr; 16(1):61. PubMed ID: 29706136 [TBL] [Abstract][Full Text] [Related]
9. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Behet MC; Foquet L; van Gemert GJ; Bijker EM; Meuleman P; Leroux-Roels G; Hermsen CC; Scholzen A; Sauerwein RW Malar J; 2014 Apr; 13():136. PubMed ID: 24708526 [TBL] [Abstract][Full Text] [Related]
10. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Sack BK; Miller JL; Vaughan AM; Douglass A; Kaushansky A; Mikolajczak S; Coppi A; Gonzalez-Aseguinolaza G; Tsuji M; Zavala F; Sinnis P; Kappe SH Infect Immun; 2014 Feb; 82(2):808-17. PubMed ID: 24478094 [TBL] [Abstract][Full Text] [Related]
14. The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19). Shi J; McIntosh RS; Adame-Gallegos J; Dehal PK; van Egmond M; van de Winkel J; Draper SJ; Forbes EK; Corran PH; Holder AA; Woof JM; Pleass RJ BMC Biotechnol; 2011 Jul; 11():77. PubMed ID: 21781305 [TBL] [Abstract][Full Text] [Related]
15. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model. Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819 [TBL] [Abstract][Full Text] [Related]
16. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909 [TBL] [Abstract][Full Text] [Related]
17. Imaging mosquito transmission of Plasmodium sporozoites into the mammalian host: immunological implications. Vanderberg JP Parasitol Int; 2014 Feb; 63(1):150-64. PubMed ID: 24060541 [TBL] [Abstract][Full Text] [Related]
18. Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection. Webster HK; Brown AE; Chuenchitra C; Permpanich B; Pipithkul J J Clin Microbiol; 1988 May; 26(5):923-7. PubMed ID: 2454941 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE Malar J; 2013 Apr; 12():136. PubMed ID: 23607541 [TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera. do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]